Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Aponia Laboratories, Inc.

Clinicaltrial registered12 Nov 2026

Aponia Laboratories, Inc.

12 Nov 2026: Trial registered · Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue Contusions. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
12 Nov 2026
Title
Effect of S-Ibuprofen Gel on Pain in Acute Soft Tissue Contusions
Conditions
Acute Pain Due to Trauma
Phase
Phase 3
Study Type
Interventional
Status
Recruiting
Countries
United States, Germany
Country
United States
Reference
NCT07930559
Location
United States, Germany
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Aponia Laboratories, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from United States

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.